Mexico and Canada partner health research:
This article was originally published in Clinica
Mexico and Canada have signed an agreement to conduct joint healthcare research. The two-year partnership will seek to promote research, not only in the most specialised fields of medicine, including genetics and genomics, but also in areas such as healthcare funding. The agreement was signed last week by Misael Uribe and Bruce Maxwell, of the Mexican office of healthcare institutes (Coordinacion de los Institutos Nacionales de Salud) and Canadian Institutes of Health Research.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.